|
C. difficile key opinion leader Wallace Greene, PhD, (ABMM) presents the topic - Detecting Clostridium difficile and addressing what are the recommendations and what are your options for testing.
|
|
|
C. difficile key opinion leader Romney Humphries, PhD M(ASCP)CM discusses the UCLA experience with C. difficile disease testing. Topics include a review of current available diagnostic testing options for C. difficile, ASM guidelines, lab testing algorithms, the illumigene® C. difficile molecular assay, and why UCLA chose the illumigene® test method.
|
|
|
C. difficile key opinion leader Erik. R. Dubberke, MD, MSPS speaks about the clinical and economic implications of the disease. Topics discussed include assessing attributable outcomes, C. difficile attributable outcomes (Costs, Morbidity, and Mortality), epidemic strain and outcomes, and laboratory role to improve outcomes.
|
|
|
C. difficile key opinion leader Kim M. Ware, RN, BSN, CIC speaks about the bacteria. Topics discussed include lessons from an outbreak, highlights from the APIC Prevalence Study, IC Practice Recommendations, and the future of C. difficile.
|
|
|
C. difficile key opinion leader Stephen M. Brecher PhD, DABMM, FAAM discusses the management of the bacteria in community settings. Topics discussed include case reports, historical prospective, organism and key properties, changing epidemiology, diagnosis and treatment, and infection control.
|
|
|
|
|
|
